Veranova and Phorum.AI Partner to Deliver Generative AI Chemistry Optimization to the Pharmaceutical & Biotech Industry

Veranova and Phorum.AI announced that they are collaborating on next-generation optimization of pharmaceutical manufacturing processes using artificial intelligence (AI) Building on years of research and experimentation by Phorum.AI co-founder and MIT Professor of Chemistry, Brad Pentelute, Phorum.AI is deploying generative AI systems to help biopharmaceutical companies rapidly develop optimized manufacturing processes that can reduce costs, […]

Singapore To Be Home To $1.5bn AstraZeneca Production Plant

On May 20, 2024, AstraZeneca, the global biopharma company, announced plans to build a $1.5 billion manufacturing facility in Singapore. With this announcement, the company is looking to start the design and construction of the new Singapore setup by the end of 2024 and make it operationally ready by 2029. With this new facility, the […]

Novo Nordisk invests ¥4 B in China for sterile preparation expansion project

Novo Nordisk has announced that it would invest approximately 4 billion yuan (¥) in Tianjin for a sterile preparation expansion project and recently held a groundbreaking ceremony for the expansion project. On the day of the event, leaders from the Danish Embassy in China and relevant commissions and bureaus of Tianjin City and Binhai New […]

WuXi AppTec breaks ground on new R&D and manufacturing site in Singapore

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, has announced the groundbreaking of its new R&D and manufacturing site in Singapore. This milestone, following the announcement of the new site in 2022, marks another step forward in WuXi […]

AstraZeneca plans $1.5 billion manufacturing facility for antibody drug conjugates (ADCs) in Singapore

AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global supply of its ADC portfolio. ADCs are next-generation treatments that deliver highly potent cancer-killing agents directly to cancer cells through a targeted antibody. The planned greenfield facility, supported by the Singapore Economic Development Board (EDB), will be […]

AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030

AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant growth in its existing oncology, biopharmaceuticals and rare disease portfolio, and by launching an expected 20 new medicines before the end of the decade. To drive sustained growth beyond […]

Germany’s Merck KGaA acquires Mirus Bio for $600 M

Gamma Biosciences, a life sciences platform established by KKR to address the advanced therapy bioprocessing market, announced that it has entered into an agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company, whereby Merck KGaA, Darmstadt, Germany, will acquire Gamma operating company Mirus Bio for $600 million in cash. Mirus Bio is […]

Pharma Chemicals Market To Grow At A CAGR of 5% Till 2029

It is worth noting that the pharmaceutical chemicals market happens to be segmented by Type which includes Reagents, Catalysts, Solvents, KSMs and intermediates, Building Blocks for APIs and Advanced Intermediaries and by Application which has in it Medical Raw Materials as well as Beauty Products. Apparently, the global pharmaceutical chemicals market size is anticipated to […]

Development and Validation of a Patient Toolkit to Help Overcome the Challenges Faced in the Management of Patients with Cirrhosis with Ascites

Executive Summary Liver disease is currently the second leading cause of years of working life lost in Europe, second only to ischaemic heart disease 1 . An analysis of the interaction between patients with cirrhosis with ascites (CwA), caregivers, and healthcare providers has shown a need to improve patient-physician coordination and guidance on lifestyle changes. […]

Europe API Market To Grow At A CAGR of Over 5.5% Till 2033

As per one of the recently held studies in 2024, the Europe Active Pharmaceutical Ingredients- API market size happened to be anticipated at $45.43 billion in 2023, and with an expected CAGR of 5.78% right from 2024 to 2033, it is expected to reach $79.69 billion in the forecast period. Some of the key findings […]